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ABSTRACT
Myocardial infarction has been carefully studied in numerous experimental models.
Most of these models are based on electrophysiological and functional data, and
pay less attention to histological discoveries. During the last decade, treatment using
advanced therapies, mainly cell therapy, has prevailed from among all the options to
be studied for treating myocardial infarction. In our study we wanted to show the
fundamental histological parameters to be evaluated during the development of an
infarction on an experimental model as well as treatment with mesenchymal stem
cells derived from adipose tissue applied intra-lesionally. The fundamental parameters
to study in infarcted tissue at the histological level are the cells involved in the
inflammatory process (lymphocytes, macrophages and M2, neutrophils, mast cells and
plasma cells), neovascularization processes (capillaries and arterioles) and cardiac cells
(cardiomyocytes and Purkinje fibers). In our study, we used intramyocardial injection
of mesenchymal stem cells into the myocardial infarction area 1 hour after arterial
occlusion and allowed 1 month of evolution before analyzing the modifications on
the normal tissue inflammatory infiltrate. Acute inflammation was shortened, leading
to chronic inflammation with abundant plasma cells and mast cells and complete
disappearance of neutrophils. Another benefit was an increase in the number of
vessels formed. Cardiomyocytes and Purkinje fibers were better conserved, both from
a structural and metabolic point of view, possibly leading to reduced morbidity in the
long term. With this study we present the main histological aspects to be evaluated
in future assays, complementing or explaining the electrophysiological and functional
findings.
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INTRODUCTION
During the last decade, many attempts have been made to develop a treatment for heart
failure using experimental models of myocardial infarction (MI). Most of the attempts
have been based on advanced therapies. Although promising advances have been achieved,
trial results have limitations in the clinical phase (Chen et al., 2014; Kim et al., 2017; Liu
et al., 2016).
The attempts that have reached clinical trial phases have used mesenchymal
stem cells (MSCs). From diverse origins, MSCs are immunoprivileged cells that are
suitable for allogeneic and xenogeneic transplantation (Aggarwal & Pittenger, 2005). As
immunomodulatory cells, they act on the injured or inflamed area by secreting various
growth factors. To do so, they stimulate the proliferation of local cells which also helps
with remodeling the local matrix. In summary, they improve both healing and repairing
of post-MI tissue (Wu et al., 2007). Currently, MSC-based therapies present a promising
treatment plan for decreasing morbidity and mortality from chronic diseases with poor
wound healing (García-Gómez et al., 2010).
To design new therapeutic approaches based on experience to date, we should consider
two important factors: selecting the correct experimental model and choosing the most
appropriate parameters to analyze.
Experimental models must meet minimum requirements, including being feasible
and reproducing human disease as closely as possible. A porcine model has proven to
be the most effective model for studying ischemic heart disease, due to the anatomical,
physiological and pathological similarities between human and pig hearts (Dixon & Spinale,
2009). Most of these models are based on surgical techniques for coronary artery occlusion
after thoracotomy (Hoffmann et al., 2004; Klocke et al., 2007; Litvak, Siderides & Vineberg,
1957) or are based on less invasive techniques (Krombach et al., 2005; Yoshimizu et al.,
1986) that reproduce the ischemic lesion as accurately as possible. The most frequently
used model involves anterior descending coronary artery occlusion (due to its simple and
reproducible approach) with occlusions at various levels and a selective venous return. In
all cases, an arterial occlusion lasting more than 1 h causes an irreversible effect similar to
a permanent occlusion (Verdouw et al., 1998).
Considering the parameters to be analyzed,most studies have focusedmainly on the acute
phase of the infarction, and results have been based on clinical and electrophysiological
parameters (Chen et al., 2014; Kim et al., 2017; Liu et al., 2016). In order to prevent and
treat pathologies derived from the affectation of the coronary arteries and consequent
cardiac failure, it is necessary to understand not only the clinical-electrophysiological
parameters but also the pathophysiology of the disease and the progress of the tissues
involved in MI.
Different types of cells have been used in experimental assays on pigs (Castro et al.,
2019; Johnson & Singla, 2017; Mohsin & Houser, 2019; Shah et al., 2018; Van der Spoel
et al., 2011; Wang et al., 2017). The types of cells that have been tested in various clinical
trials (http://www.clinicaltrials.gov) with disappointing results have included bone
marrow mononuclear cells (BMNCs), bone marrow mesenchymal stem cells(BMSCs),
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mesenchymal cells derived from adipose tissue (ASCs) and, more recently, pre-derived
embryonic cells (ESCs), induced pluripotent stem cells (iPSCs) and cardiac progenitor
cells (CSCs) (Higuchi et al., 2017).
We used a model of descending coronary artery occlusion to describe the
pathophysiology of the process and the intracardiac injection of adipose-derived
mesenchymal stem cells (ASCs), a type of MSCs that are abundant and easy to obtain, to
analyze histological changes in both the infarcted tissue and the adjacent area. In this way,
we were able to observe the effects of the intralesional application of ASCs.
Our research involved analyzing the changes that occurred during the inflammatory
process, cicatrization and neovascularization, all of which are characteristic events in
post-MI tissue regeneration. In addition, we studied the state of conservation of cardiac
cells, cardiomyocytes and Purkinje fibers close to the infarcted region. To that end, we
created an MI occluding the left anterior descending coronary artery and we compared the
experimental treatment (intralesional injection of 5× 106 cells, MI + ASC group) with the
natural evolution of infarcted tissue (saline injection, Myocardial Infarction Control (MIC)
group). All the animals were euthanized after 4 weeks. Our objective was to determine,
from a histopathological point of view, the effect of ASCs on the previously discussed
patterns that are fundamental to understanding the functional consequences of long-term
post-MI.
With this study we explored the main histological aspects to be evaluated in assays in
MI animal models treated by stem cells. These studies can add rationality to understanding
the electrophysiological and functional findings.
MATERIALS AND METHODS
Animals
Nine Landrace-Large White pigs 23–28 kg were used: one was male -used to obtain
ASCs from subcutaneous adipose tissue- and the rest were females destined for the
intervention. All procedures were performed in the Experimental Surgery Department of
La Paz University Hospital in Madrid, Spain. We followed the protocol approved by the
Animal Welfare Ethics Committee (CEBA 14-2011) and complied with the EU Directive
on experimental animals (63/2010 EU) and related Spanish legislation (RD 53/2013).
Surgery
Twenty-four hours before surgery, the animals were pre-medicated with a fentanyl patch,
and were administered 12 mg/kg ketamine (im), midazolam 0.5 mg/kg (im), and tramadol
5 mg/kg (im) 15 min before the intervention. The animals were anesthetized using
isoflurane 2% and a continuous infusion of morphine (12 mg), ketamine (30 mg) and
lidocaine (15 mg) in 500 ml saline solution at a rate of 10 ml/kg/h throughout the
intervention.
A lateral thoracotomy was performed, and the anterior descending artery was ligated
by 6/0 silk suture (Ethicon). One hour after ligation, 5 × 106 stem cells or saline solution
(1 ml) were delivered by syringe into the myocardial ischemic tissue around the infarct
area (at 3 points). After surgery, the animals were kept individually isolated in a 2 m2 space
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with controlled food and water ad libitum. Analgesia was provided with a fentanyl patch
every 2 days for a week, and the animals tolerated food the day after surgery. Ceftriaxone
40 mg/kg (im) was used as antibiotic prophylaxis from 3 days before until 72 h after the
intervention.
Isolation of Adipose-Derived Mesenchymal Stem Cells
Adipose tissue-derived stem cells (ASCs) were obtained from an animal of the same breed
according to a previously described protocol with minor modifications (Zuk et al., 2001).
After that, the cells were expanded in culture with Dulbecco’s Modified Eagle’s Medium,
supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin at 37 ◦C and
5%CO2. The cells were characterized by flowing cytometry and differentiated as adipocytes,
osteocytes and chondrocytes, confirming that we were working with mesenchymal stem
cells according to International Federation for Adipose Therapeutics criteria (Bourin et al.,
2013). Finally, the cells were expanded in vitro and aliquots of 5 million were frozen with
10% dimethyl sulfoxide and stored in liquid nitrogen after use.
One week before the intervention, the required aliquots were defrosted and cultured
until a sufficient number was obtained (5 × 106 cells/animal). Before use, the cells were
detached from the culture with trypsin-EDTA and were washed three times with phosphate
buffered saline (PBS, Gibco).
Prior to injection, they weremarkedwith CelltrackerDil (Invitrogen, Carlsbad, CA,USA)
according to the manufacturer’s instructions in order to identify ASCs in animal tissue
samples. The cells were located in red spectra (553/570 nm) by fluorescence microscopy.
Obtaining Samples
In all cases, a 2 mL sample of blood was drawn prior to surgery and 24, 48 and 72 h
post-surgery, for the purpose of analyzing troponin and biochemical parameters.
All animals were euthanized 1 month after surgery by intravenous injection of 5M
potassium chloride, having previously been anesthetized using isoflurane 2%. The hearts
were extracted and washed with 10% formaldehyde through the coronary artery and
mitral valve. Once the tissues were fixed, samples were obtained from the infarct area and
periphery.
Histological analysis
Five mm3 samples were fixed in 10% formaldehyde at room temperature, embedded in
paraffin and cut into 5-micron-thick slices in a Micron HM360 microtome.
Sections were stained with hematoxylin-eosin to identify plasma cells, lymphocytes,
neutrophils and capillaries, using toluidine blue for the identification of mast cells.
For the immunohistochemical studies, histology sections were deparaffinized and
rehydrated before endogenous peroxidase activity was blocked with H2O2 (0.3%) in
methanol. The slides were rinsed with PBS and incubated with primary antibodies in
a moist chamber at room temperature. The sections were subsequently incubated with
biotinylated anti-rabbit IgG and LBA (DAKO) for 25 min at room temperature, rinsed
with PBS and immersed for 25 min in avidin peroxidase. The immunostaining reaction
product was developed using diaminobenzidine. Counter staining was performed with
García Gómez-Heras et al. (2019), PeerJ, DOI 10.7717/peerj.7160 4/20
hematoxylin. The specificity of the immunohistochemical procedure was confirmed by
incubation of sections with non-immune serum instead of a primary antibody.
The primary antibodies used were anti-CD14 antibody (MyBioSource, MBS-2027456,
1/500), anti-CD163 antibody (Serotec, MCA242GA, 1/200), muscle specific actin
monoclonal antibody (Novocastra, A7811, 1/100), Desmin Monoclonal Antibody
(Novocastra, DE-R11, 1/50), Connexin 43 mouse monoclonal antibody (Cell Signaling
Technology, cst-3512, 1/50), and HIF1-α antibody (Gene Tex, GTX 30105, 1/1000).
The Masson trichrome technique was used to evaluate the degree of fibrosis (percentage
of collagen area [blue] versus tissue area [red]).
All histological slides were studied under a Zeiss Axiophot 2 microscope and
photographed with an AxiocamHRc camera. Twenty contiguous non-overlapping fields
(200× or 400×) per slide from each group were counted according to the Novotny et al.
(2018) and the Yuetal2018 protocols. All the cells were quantified by the same researcher
without knowledge of the groupings.
Statistical analysis
Heart rate differences between groups were assessed using the corrected chi-squared test.
Results with a p value of less than 0.05 were considered significant.
RESULTS
Animal model
The experimental animal model we created showed high infarction reproducibility due
to occlusion of the left anterior descending coronary artery in its upper third, as well as a
high animal survival rate (90%). In all cases, the necrotic tissue was in the same anatomical
region, was approximately 1.4 cm (±0.2) in diameter, and was associated with ST elevation
as shown in the electrocardiogram. Subsequently, MI was confirmed by a >20% increase
in basal troponin levels at 24 h post occlusion and a decrease of those levels by about 50%
at 48 h.
ASC location after injection
Immunohistological detection of the DiL signal in the cicatricial region was observed in
the IM + ASC group after one month. As expected, no positive DiL signal was observed in
the control hearts (Fig. 1).
Histological results (Tables 1 and 2)
Inflammatory reaction
After the quantitative analysis of the infarcted area, we observed a greater infiltration of
plasma cells andmast cells (2:1) in the animals treated with ASCs (MI + ASCs). In addition,
the quantity of the neutrophils was less (1:3) and the number of lymphocytes was similar
in both groups.
The amount of CD14+ macrophages quantified in the infarcted area was greater in the
MIC group. CD163+macrophages were present in greater amounts in theMI + ASC group
(15.17% of CD14+ macrophages were CD163+). In the MIC group, 4.95% of the CD14+
macrophages were CD163+ (Fig. 2).
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Figure 1 Adipose Stem Cells in the myocardium of MI+ASC heart group. (A, C and E) Fluorescence
Microscopy Celltracker Dil 400×; (B, D, and F) Hematoxylin-eosin, 400×.
Full-size DOI: 10.7717/peerj.7160/fig-1
We did not find inflammatory infiltrate outside the infarct area in any of the animal
groups studied.
Vascular density
The number of capillaries was similar in both groups. We found more arterioles in the
scarring region of the hearts belonging to the MI + ASC group than in the MIC group (at
a ratio of 3:2) (Figs. 3A–3B).
García Gómez-Heras et al. (2019), PeerJ, DOI 10.7717/peerj.7160 6/20
Table 1 Histological results in the scar area.
SCAR AREA
MI+ASCs MIC
PLASMA CELLS 20X* (x¯ ± se) 8.73± 0.50 3.7± 0.41
NEUTROPHILS 40X* (x¯ ± se) 9.05± 0.68 12.86± 0.74
LYMPHOCYTES 40X (x¯ ± se) 8.46± 0.75 7.06± 0.55
MAST CELLS 20X* (x¯ ± se) 1.34± 0.17 0.51± 0.11
MACROPHAGES 20x (x¯ ± se) 13.97± 0.94 15.12± 0.81
MACROPHAGES M2 20X* (x¯ ± se) 2.65± 0.38 0.75± 0.13
CAPILLARIES (x¯ ± se) 9.02± 0.57 9.38± 0.64
ARTERIOLES (x¯ ± se) 3.13± 0.23 2.31± 0.19
SCAR AREA (µm2) 26.15± 1.96 23.18± 2.02
SCAR FIBROSIS DENSER LAX
Notes.
*P < 0.05.
se, standard error; x¯ , average.
Table 2 Histological condiction of cardiac cells in the pericicatricial zone.
PERICICATRICIAL ZONE
CARDIOMYOCYTES PURKINJE FIBERS
MI+ASCs MIC MI+ASCs MIC
LOSS OF THE ACTINE PATTERN + ++ ++ +++
LOSS OF THE DESMIN PATTERN + ++ + ++
CHANGES IN GAP JUNCTION + ++ + ++
NUCLEOUS POSITIVEFOR ANTI- HIF-1α
ANTIBODY*(% positive nuclei)
34.75(45.006%) 13.75(18.1%) 5.63 (56.44%) 4.32(23.64%)
Notes.
-, NONE; +, MILD; ++, MODERATE; +++, SEVERE.
*P < 0.05.
Collagen deposition
A denser and more organized scar was found in the MI + ASC group than in the MIC
group. In both groups, fibrosis extension was similar (Figs. 3C–3D).
Cardiomyocytes in the peri-cicatricial region
The MI + ASC group had better conservation of the cytoskeleton than the MIC group
based on actin/desmin staining (Figs. 4A–4D).
Studying the distribution of Connexin 43 cells, we observed that, in theMI + ASC group,
there was protein expression, and its distribution was conserved. In the MIC group, the
expression of Connexin 43 was reduced and its distribution was altered (Figs. 4E–4F).
Immunohistochemistry revealed HIF1-α protein throughout areas of perinfarcted
myocardium. In the MI + ASC group, 45% of the cardiomyocytes had positive nuclei
for HIF-1α, whereas in the MIC group, only 18.1% of them were positive (p< 0.05)
(Figs. 4G–4H).
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Figure 2 Macrophages in the peri-cicatricial area. The number of macrophages (arrow) in the peri-
cicatricial area of MI+ASC heart (A) is similar to MIC group (B). Immunohistochemistry anti-CD14,
PAP. 400×. M2 macrophages (arrows) are in greater proportion in MI+ASC group (C) than in MIC (D).
Immunohistochemistry anti-CD163 PAP. 400×.
Full-size DOI: 10.7717/peerj.7160/fig-2
Purkinje fibers in the peri-cicatricial region
The structure of the cytoskeleton of the MI + ASC group was well preserved, whereas in
the MIC group we observed a decrease of filaments (Figs. 5A–5D).
The immunohistochemical technique reflected a decrease in the expression of Connexin
43 cells in the gap junctions of the Purkinje fibers in the MI + ASC group, a decrease
that was even more marked in the MIC group, in which its distribution was irregular
(Figs. 5E–5F).
Based on the expression of HIF-1α, immunoreactivity was observed in the nuclei of
the Purkinje fibers throughout the areas of perinfarcted myocardium and was not present
in non-infarcted myocardium. In the MI + ASC group, 56.44% of the Purkinje fibers
had positive nuclei, whereas in the MIC group, only 23.64% had positive HIF-1α nuclei
(p< 0.05) (Figs. 5G–5H).
DISCUSSION
Various studies have been published on myocardial infarction models after a permanent
ligation, especially in the acute phase. Most of these have focused on evaluating the
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Figure 3 Scarring region. Capillaries (asterisk) and arterioles (arrows) in the scarring region of MI+ ASC
hearts (A) and MIC hearts (B). Hematoxylin-eosin, 200×. Denser scar in ASC group (C) than in Control
group (D). Masson, 200×.
Full-size DOI: 10.7717/peerj.7160/fig-3
functionality and electrophysiology of the proposed treatments (De Siena et al., 2010; Kim
et al., 2017).
In our study, we emphasized the pathological aspects more than the electrophysiological
ones. At the electrophysiological level, we observed a decrease in systolic and diastolic
pressure after the infarction which, although it did not normalize completely, improved
hours after the infarction. Although this normalization was not significant, it was observed
earlier in the animals treated with cells. Also, we observed a decrease in heart rate in
animals treated with cells less than one hour post-cell injection, which implies a lower
cardiac output and an improvement in the state of the animals. At the blood protein level,
the most significant parameter was troponin, and we observed post-infarct that troponin
levels decreased at 48 hmore than 50% in animals treated with cells, while the control group
did not reach a 50% decrease in that period of time. These better data in the group treated
with cells coincides with the pathophysiological data described: a lower inflammatory
infiltrate, less fibrosis and a better conservation of the parenchyma.
For our study, we analyzed the three main factors that could lead to an increase in
post-infarction morbidity: a chronic inflammatory process, scarring characteristics and
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Figure 4 Cardiomyocytes in the peri-cicatricial zone. Labeling of actin demostrate little areas with loss
of actine expression in MI+ASC hearts (A), in MIC group (B) actin pattern is lost in bigger zones (aster-
isk). We can see cells with contraction-bands (yellow arrows). Immunohistochemistry anti-actin, PAP.
200× Desmin expression is better conserved (white arrows) in MI+ASC group (C) than MIC group (D,
yellow arrows). Immunohistochemistry anti-desmin, PAP. 200×. Greater number of HIF-1α-positive nu-
clei (white arrows) in MI+ASC (E) than in MIC group (F, yellow arrows). Immunohistochemistry anti-
HIF1-α, PAP. 400×. Connexin 43 is better conserved in MI+ASC hearts (G, white arrows) than in MIC
hearts (H) where it is diminished and granular (yellow arrows). Immunohistochemistry anti connexin 43,
PAP. 200×.
Full-size DOI: 10.7717/peerj.7160/fig-4
the status of myocardial cells remaining around the infarcted area, at a time specific to its
evolution and comparing a normal evolution with experimental cell therapy treatment.
One of the main goals in regenerative medicine and tissue engineering in the MI field
is initial inflammatory response modulation. As Kocher et al. (2001) had already reported
on the anti-inflammatory effect of Mesenchymal Stem Cells (MSCs) in myocardial infarct.
Since then, numerous research groups have published articles referring to multiple reasons
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Figure 5 Purkinje fibres in the peri-cicatricial zone. Actine filaments in the Purkinje fibers are better
conserved in MI+ASC (A, white arrows) than in MIC ones (B, yellow arrows). Immunohistochemistry
anti-actin, PAP. 200×. Most of the desmine filaments are better conserved in MI+ASC group (C, white ar-
rows) than in the MIC group hearts (D, yellow arrows). Immunohistochemistry anti-desmin, PAP. 200×.
More positive nuclei (white arrows) in the cells of pericicatricial zone in MI+ASC group (E) than in con-
trol group (F, yellow arrows). Immunohistochemistry anti- HIF1-α, PAP. 400×. Better conserved pattern
of connexin 43 between Purkinje fibers in MI+ASC group (G, white arrows) than in control group where,
also, it is diminished (H, yellow arrow). Immunohistochemistry anti-connexin 43, PAP. 400×.
Full-size DOI: 10.7717/peerj.7160/fig-5
for the infusion of MSC to shorten and regulate the inflammatory process, for example
the regulating T or T-native cells, the M1/M2 macrophage transition, the secretion of
interleukins like IL10 or IL-4. (Najar et al., 2016; Krampera et al., 2003; Yañez et al., 2010;
Hirose et al., 2018). Actually, many studies have been carried out and they all have found
different reasons to explain this shortening of the acute inflammatory process, but there
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may bemany other aspects that generate this effect as suggested in 2012 byGeorgiev-Hristov
et al. (2012).
The principal problem is a prolongation of the inflammatory phase during the wound
healing process leading to adverse scarring and causing medium/long term cardiac failure
(Chen & Frangogiannis, 2016; Leor et al., 2016). Along these lines, it is necessary to analyze
the qualitative histological characteristics of that reaction: it should attract reparative cells,
such as M2 macrophages, which favor the formation of well vascularized tissue, and with
the right proportion of collagen for proper ventricular function.
Our results show that plasma cells decrease in the infarcted tissue in an untreated heart.
However, they were attracted to the inflammatory-reparative area by the ASCs and they
infiltrated the infarcted tissue of the hearts treated with ASCs. Similar to other authors
(Mazo et al., 2012; Rasmusson et al., 2005; Rasmusson et al., 2007), we consider that this
increase in plasma cells in the treated animals might be due to the paracrine activity of
mesenchymal cells.
When we analyzed the various cells involved in the inflammatory process, we found that
the control groupmaintained a highnumber of neutrophils and an increase inmacrophages,
which reveals an acute inflammation or an initial phase of a chronic inflammatory stage.
On the other hand, ASC treatment caused late chronic phase development of a decrease in
neutrophil number and an increase in type 2 macrophages. This outcome might be due to
the anti-inflammatory effect of ASCs (García-Gómez et al., 2010; Kuo et al., 2012; Van den
Akker, De Jager & Sluijter, 2013) and the shortening of the inflammatory-reparative process
generated by the ASCs.
Another interesting result that we observed was that mast cell infiltration in the infarcted
area was three times higher in the ASC-treated animals. We believe the lack of statistical
significance between both groups was due to the fact that this infiltration by mast cells in
an MI persists during the inflammatory process from the chronic stage (Levick et al., 2011;
Reid et al., 2011). The mast cells seem to be involved in the paracrine regulation of growth
factors (GF) in the infarcted area, although their exact functions must be further studied
(Gentek & Hoeffel, 2017).
Macrophages change their phenotype and function in response to signals from the
microenvironment. The M1/M2 balance may influence cardiac repair improvement and
post-MI function (Leor et al., 2016; Gombozhapova et al., 2017). Therefore, this approach
could be used as a therapeutic tool. Interactions betweenASCs andmacrophages are known:
ASCs increase the expression of theM2 phenotype (Ryabov et al., 2018). In post-MI healing,
a prolonged presence of M1 macrophages can lead to an increase in the size of the MI area
and prevent correct resolution. We observed this increase of the MI area in our control
animals. On the other hand, in treated animals we observed an increase inM2macrophages
to implicate a diminution inMI area. Our results, in accordance with previous data, showed
a better condition of the infarcted tissue in the IM-ASC group animals.
Also, ASCs present angiogenic effects when implanted in infarcted tissue. Numerous
published studies have demonstrated this approach (Chou et al., 2014; Citro et al., 2014;
Kim et al., 2014). In our study, after 1 month of evolution of the ASC group, we did not
observe an increase in capillaries. Although we detected a greater number of arterioles,
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the difference was not statistically significant. We believe that 1 month of evolution of
the infarction led to stabilization of the angiogenesis of the infarcted region. A study with
analysis of shorter periods could possibly clarify this difference.
In our study we observed a dense scar associated with better organization of collagen
type I in the ASC group, that possibly explained the better remodeling of the perinfarcted
tissue and the generation of a more organized scar. Results are in accordance with those
observed by other authors (Nong et al., 2011; Yu et al., 2018a; Yu et al., 2018b).
Free radical cardiac myoglobin and other sources play an important role in myocardial
infarction (Zhu & Zuo, 2013). These oxygen radicals can potentially influence cardiac
inflammation and the survival rates of injected stem cells. Thus, further studies into the
correlation between reactive oxygen species and inflammation should be carried out in the
future.
Finally, we determined the survival conditions of cardiac cells, cardiomyocytes and
Purkinje cells. Different studies had previously implicated both cell types in remodulation
of infarct tissue and a positive response to MSC treatment (Li et al., 2010;Muguruma et al.,
2006; Shafei et al., 2017; Yoon et al., 2005). In general, we can conclude that in the MI +
ASC group after 4 weeks of post infarction evolution, the cardiomyocytes and Purkinje cells
were better conserved, and we can affirm this point by Connexin 43 and HIF1-α status.
From both qualitative and quantitative points of view, the cytoskeleton filaments of these
cells and the gap junctions (Connexin 43) in ASC group were similar to non-pathological
conditions. After tissue hypoxia, affected cardiac cells respond to variousmechanisms aimed
at restoring cellular oxygen levels. One of the main response pathways is the inhibition of
hydroxylation of HIF1-α by prolyl hydroxylases (PHDs), which translocate to the nucleus,
initiating the transcription of factors that support normoxia: promoting angiogenesis,
increasing cell proliferation and migration, stimulating glycolysis, etc. With all this activity,
cell survival is more likely (Szade et al., 2015). Thus, stabilization and accumulation of
HIF1-α is considered cardioprotective, helping preserve myocardial structure and function
(Cheng et al., 2016; Lee et al., 2000; Townley-Tilson, Pi & Xie, 2015;Wu et al., 2015). After 4
weeks of postinfarction evolution, we observed how the presence of ASCs coincided with
a greater proportion of cardiomyocytes and Purkinje fibers expressing nuclear HIF1-α
with respect to the control group. Therefore, in these ASC-treated hearts, there was a more
intense adaptive response to hypoxia conditions. Given that HIF1- α is a mechanism which
starts immediately after the decrease in oxygen levels, it was maintained 4 weeks after MI,
especially in the MI-ASC group.
We have also demonstrated that the infarction model carried out by the occlusion of
the anterior coronary artery was reproducible. One month of evolution represents a period
that is similar to what we observe in the clinic.
In conclusion, in this study we have shown the main histological parameters to be
assessed after the generation of an infarction: the cells involved in the inflammatory process,
cicatricial and neovascularization processes characteristic of post-MI tissue regeneration
as well as in the conservation of cardiac cells, cardiomyocytes and Purkinje fibers adjacent
to the infarcted area. Finally we used Stem Cell treatment to demonstrate the implications
of these histological parameters in infarct tissue remodulation.
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Thus, in this study, we propose what we consider to be the main histological aspects
to be evaluated in future assays, and provide complementary explanations for the
electrophysiological and functional findings.
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